Similar to other rare cancers, the cholangiocarcinoma community faces challenges of late and inadequate diagnosis, lack of tumor tissue, lack of clinical expertise, lack of research resources, and limited treatment options.

 

If you are facing these challenges, we are here to help you and your patients by providing several educational tools, information about clinical trials, and research resources.